2026 data Public-data reference. official source

System, Test, Automated Blood Grouping And Antibody

Open-data reference.

FDA MAUDE adverse event data · 1994–2026

What the Data Shows About System, Test, Automated Blood Grouping And Antibody

The FDA MAUDE database aggregates 10,382 adverse-event reports for System, Test, Automated Blood Grouping And Antibody spanning the period from 1994 through 2026. Of these, 6 are classified as death reports, 100 as injury reports, and 9,991 as malfunction reports under FDA adverse-event categorization rules. Report counts do not by themselves indicate a device is unsafe — widely used devices and longer market histories naturally generate larger raw counts, so proportional and comparative reads are more informative than totals alone.

The adverse-event profile breaks down across 5 distinct event types and 11 reported patient-outcome categories, giving a multi-dimensional view that goes beyond a single headline number. A total of 20 distinct product-problem codes appear in the reports, with False Negative Result topping the list at 1,651 reports. Reports are associated with 10 different manufacturers in the MAUDE record, reflecting both OEMs and repackagers of this device category.

Annual reporting volume is tracked across 31 years of MAUDE data, with the peak single-year volume reaching 1,047 reports — trend shape often reflects changes in device adoption, reporting rules, or FDA enforcement focus rather than underlying device behavior alone. Events are documented across 10 reported care-setting categories (hospital, home, ambulatory surgery center, etc.). All figures reflect the openFDA MAUDE snapshot last refreshed on . This page is informational and is not medical advice — discuss device-safety questions with your healthcare provider.

10,382
Total Reports
6
Death Reports
100
Injury Reports
9,991
Malfunctions

Event Types

Malfunction 9,991 (96.2%)
Other 257 (2.5%)
Injury 100 (1.0%)
28 (0.3%)
Death 6 (0.1%)

Patient Outcomes

9,352 (90.0%)
Other 1,005 (9.7%)
Death 8 (0.1%)
Required Intervention 7 (0.1%)
Hospitalization 6 (0.1%)
Congenital Anomaly 5 (0.0%)
O 4 (0.0%)
R 2 (0.0%)
H 1 (0.0%)
L 1 (0.0%)
Disability 1 (0.0%)

Top Product Problems

False Negative Result 1,651
False Positive Result 367
Incorrect, Inadequate or Imprecise Result or Readings 354
Incorrect Or Inadequate Test Results 150
Adverse Event Without Identified Device or Use Problem 83
Device Operates Differently Than Expected 53
Defective Component 49
Defective Device 42
Improper or Incorrect Procedure or Method 30
Computer Software Problem 19
Display Difficult to Read 16
Incorrect Measurement 12
Low Readings 11
Device Displays Incorrect Message 10
Data Problem 9
Leak/Splash 9
Electrical /Electronic Property Problem 8
Insufficient Information 8
Output Problem 8
Contamination 7

Yearly Trend

94
1994: 2
97
1997: 1
98
1998: 2
99
1999: 2
00
2000: 29
01
2001: 5
02
2002: 21
03
2003: 350
04
2004: 264
05
2005: 308
06
2006: 719
07
2007: 927
08
2008: 1,047
09
2009: 736
10
2010: 520
11
2011: 558
12
2012: 586
13
2013: 542
14
2014: 526
15
2015: 485
16
2016: 620
17
2017: 626
18
2018: 686
19
2019: 298
20
2020: 75
21
2021: 76
22
2022: 78
23
2023: 151
24
2024: 66
25
2025: 66
26
2026: 10

Related Entities for System, Test, Automated Blood Grouping And Antibody

Event Locations

6,955 (67.0%)
I 2,592 (25.0%)
INVALID DATA 582 (5.6%)
NO INFORMATION 183 (1.8%)
OTHER 30 (0.3%)
HOSPITAL 23 (0.2%)
AMBULATORY SURGICAL FACILITY 12 (0.1%)
BLOOD BANK 3 (0.0%)
NOT APPLICABLE 1 (0.0%)
NURSING HOME 1 (0.0%)

Compare IMMUCOR, INC. vs MICRO TYPING SYSTEMS, INC. →

Data Source

FDA Manufacturer and User Facility Device Experience (MAUDE) database via the openFDA API. Reports are submitted by manufacturers, healthcare facilities, and patients. Report counts do not indicate a device is unsafe — higher-use devices naturally generate more reports.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the FDA MAUDE database. Consult a qualified professional before making decisions based on this data.